CNS pipeline · person

Daniel Umbricht, MD

Head of Clinical Development at Gilgamesh Pharmaceuticals. Previously Head of Early Clinical Research in Neuroscience at Roche and an academic at the University of Zurich.

  • 1 company

Current roles

Appears with

People sharing a company with Daniel.

People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.